Business Context and Reporting Period
This Form 8-K Current Report, filed on November 14, 2024, by Quaker Chemical Corporation (NYSE: KWR), details significant changes to the Company's executive leadership and Board of Directors. The report covers events effective November 18, 2024.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive appointments, departures, and associated compensation arrangements.
Material Changes
- Appointment of New CEO: Joseph A. Berquist, previously the Chief Commercial Officer, was appointed Chief Executive Officer and President, effective November 18, 2024. He was also appointed to the Board of Directors as a Class I director.
- Departure of Former CEO: Andrew E. Tometich ceased serving as Chief Executive Officer, President, and Board member effective November 18, 2024. His departure is described as an involuntary termination without cause and is not related to any disagreement with the Company.
Compensation, Outlook, and Risks
New CEO Compensation (Joseph A. Berquist)
- Base Salary: $800,000 per annum.
- Annual Incentive: Target award of 100% of base salary for 2025, contingent on financial results.
- Long-Term Incentive: Target value of $2,300,000 in a mix of time-based restricted stock units and performance stock units.
- Severance: 18 months of base salary and target bonus if terminated without Cause, Death, or Disability.
- Change in Control: Entitled to severance equal to two times the sum of highest annualized base salary plus the average annual incentive compensation over the applicable three-year period if terminated within two years of a change in control.
Former CEO Severance (Andrew E. Tometich)
- Entitled to severance payments and benefits as set forth in his September 2, 2021 Employment Agreement.
- Eligible for a prorated incentive award payout under the Company's annual incentive plan.
- Payments are subject to the execution of a customary release of claims.
The filing does not provide updated financial guidance, management commentary on future operations, or specific risk factors beyond standard employment contract terms.
Investor Verification Checklist
- Verify the full text of the Employment Agreement (Exhibit 10.1) and Change in Control Agreement (Exhibit 10.2) for specific definitions of "Cause," "Disability," and "Good Reason."
- Review the Company's proxy statement filed on March 28, 2024, for details on the standard forms of agreements referenced for other executive officers.
- Confirm the exact terms of the prorated incentive award for the departing CEO, Andrew E. Tometich, as these are not explicitly quantified in this summary.
- Monitor subsequent filings for the Company's official press release (Exhibit 99.1) for additional context on the leadership transition.